The association between COVID-19 infection and incident atrial fibrillation: results from a retrospective cohort study using a large US commercial insurance database

Background We sought to examine a 1-year incidence of atrial fibrillation (AF) among patients with SARS-CoV-2 virus (COVID-19) in comparison to those with non-COVID-19 acute upper respiratory infection (AURI).Methods Patients with a diagnosis of COVID-19 (in any setting) between April 2020 and June...

Full description

Bibliographic Details
Main Authors: Tara Beaulieu, Rahul Khanna, Adam Berman, Maximiliano Iglesias
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/10/2/e002399.full
_version_ 1797366818210316288
author Tara Beaulieu
Rahul Khanna
Adam Berman
Maximiliano Iglesias
author_facet Tara Beaulieu
Rahul Khanna
Adam Berman
Maximiliano Iglesias
author_sort Tara Beaulieu
collection DOAJ
description Background We sought to examine a 1-year incidence of atrial fibrillation (AF) among patients with SARS-CoV-2 virus (COVID-19) in comparison to those with non-COVID-19 acute upper respiratory infection (AURI).Methods Patients with a diagnosis of COVID-19 (in any setting) between April 2020 and June 2021 were identified in Optum Clinformatics. Two comparator cohorts were constructed: an ‘AURI pandemic’ cohort (AURI diagnosis between April 2020 and June 2021) and an ‘AURI prepandemic’ cohort (AURI diagnosis between January 2018 and December 2018). One-year incidence of AF was compared among: COVID-19 versus AURI pandemic cohort; COVID-19 versus AURI prepandemic cohort; and AURI pandemic versus AURI prepandemic cohort. For each comparison, we applied a matching weights technique to balance covariates. Logistic regression was used to compare the odds of incident AF among the matched cohorts.Results When comparing the matched COVID-19 (n=102 227) cohort with the AURI pandemic (n=102 101) cohort, higher incidence of AF was observed among the COVID-19 cohort (2.2% vs 1.2%; p<0.001; OR 1.83; 95% CI 1.72 to 1.95). Similar findings were observed for the COVID-19 (n=169 687) versus AURI prepandemic (n=169 486) comparison (2.7% vs 1.6%; p<0.001; OR 1.70; 95% CI 1.63 to 1.78). When comparing the AURI pandemic (n=1 26 392) versus AURI prepandemic (n=1 26 394) cohort, no significant differences in incident AF were observed (1.1% vs 1.2%; p=0.133; OR 0.95, 95% CI 0.90 to 1.01).Conclusion Patients diagnosed with COVID-19 were found to be at a higher risk of incident AF as compared with those with AURI. Timely diagnosis and appropriate treatment of AF may potentially mitigate the burden of AF conferred by COVID-19.
first_indexed 2024-03-08T17:10:03Z
format Article
id doaj.art-b3c70d9b667e42718f0c195a519460d1
institution Directory Open Access Journal
issn 2053-3624
language English
last_indexed 2024-03-08T17:10:03Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Open Heart
spelling doaj.art-b3c70d9b667e42718f0c195a519460d12024-01-04T00:25:08ZengBMJ Publishing GroupOpen Heart2053-36242023-11-0110210.1136/openhrt-2023-002399The association between COVID-19 infection and incident atrial fibrillation: results from a retrospective cohort study using a large US commercial insurance databaseTara Beaulieu0Rahul Khanna1Adam Berman2Maximiliano Iglesias3MedTech Epidemiology & Data Sciences, Johnson & Johnson, New Brunswick, New Jersey, USAMedTech Epidemiology & Data Sciences, Johnson & Johnson, New Brunswick, New Jersey, USABaptist Heart, Mississippi Baptist Health Systems, Jackson, Mississippi, USAFranchise Health Economics and Market Access, Johnson & Johnson, Irvine, California, USABackground We sought to examine a 1-year incidence of atrial fibrillation (AF) among patients with SARS-CoV-2 virus (COVID-19) in comparison to those with non-COVID-19 acute upper respiratory infection (AURI).Methods Patients with a diagnosis of COVID-19 (in any setting) between April 2020 and June 2021 were identified in Optum Clinformatics. Two comparator cohorts were constructed: an ‘AURI pandemic’ cohort (AURI diagnosis between April 2020 and June 2021) and an ‘AURI prepandemic’ cohort (AURI diagnosis between January 2018 and December 2018). One-year incidence of AF was compared among: COVID-19 versus AURI pandemic cohort; COVID-19 versus AURI prepandemic cohort; and AURI pandemic versus AURI prepandemic cohort. For each comparison, we applied a matching weights technique to balance covariates. Logistic regression was used to compare the odds of incident AF among the matched cohorts.Results When comparing the matched COVID-19 (n=102 227) cohort with the AURI pandemic (n=102 101) cohort, higher incidence of AF was observed among the COVID-19 cohort (2.2% vs 1.2%; p<0.001; OR 1.83; 95% CI 1.72 to 1.95). Similar findings were observed for the COVID-19 (n=169 687) versus AURI prepandemic (n=169 486) comparison (2.7% vs 1.6%; p<0.001; OR 1.70; 95% CI 1.63 to 1.78). When comparing the AURI pandemic (n=1 26 392) versus AURI prepandemic (n=1 26 394) cohort, no significant differences in incident AF were observed (1.1% vs 1.2%; p=0.133; OR 0.95, 95% CI 0.90 to 1.01).Conclusion Patients diagnosed with COVID-19 were found to be at a higher risk of incident AF as compared with those with AURI. Timely diagnosis and appropriate treatment of AF may potentially mitigate the burden of AF conferred by COVID-19.https://openheart.bmj.com/content/10/2/e002399.full
spellingShingle Tara Beaulieu
Rahul Khanna
Adam Berman
Maximiliano Iglesias
The association between COVID-19 infection and incident atrial fibrillation: results from a retrospective cohort study using a large US commercial insurance database
Open Heart
title The association between COVID-19 infection and incident atrial fibrillation: results from a retrospective cohort study using a large US commercial insurance database
title_full The association between COVID-19 infection and incident atrial fibrillation: results from a retrospective cohort study using a large US commercial insurance database
title_fullStr The association between COVID-19 infection and incident atrial fibrillation: results from a retrospective cohort study using a large US commercial insurance database
title_full_unstemmed The association between COVID-19 infection and incident atrial fibrillation: results from a retrospective cohort study using a large US commercial insurance database
title_short The association between COVID-19 infection and incident atrial fibrillation: results from a retrospective cohort study using a large US commercial insurance database
title_sort association between covid 19 infection and incident atrial fibrillation results from a retrospective cohort study using a large us commercial insurance database
url https://openheart.bmj.com/content/10/2/e002399.full
work_keys_str_mv AT tarabeaulieu theassociationbetweencovid19infectionandincidentatrialfibrillationresultsfromaretrospectivecohortstudyusingalargeuscommercialinsurancedatabase
AT rahulkhanna theassociationbetweencovid19infectionandincidentatrialfibrillationresultsfromaretrospectivecohortstudyusingalargeuscommercialinsurancedatabase
AT adamberman theassociationbetweencovid19infectionandincidentatrialfibrillationresultsfromaretrospectivecohortstudyusingalargeuscommercialinsurancedatabase
AT maximilianoiglesias theassociationbetweencovid19infectionandincidentatrialfibrillationresultsfromaretrospectivecohortstudyusingalargeuscommercialinsurancedatabase
AT tarabeaulieu associationbetweencovid19infectionandincidentatrialfibrillationresultsfromaretrospectivecohortstudyusingalargeuscommercialinsurancedatabase
AT rahulkhanna associationbetweencovid19infectionandincidentatrialfibrillationresultsfromaretrospectivecohortstudyusingalargeuscommercialinsurancedatabase
AT adamberman associationbetweencovid19infectionandincidentatrialfibrillationresultsfromaretrospectivecohortstudyusingalargeuscommercialinsurancedatabase
AT maximilianoiglesias associationbetweencovid19infectionandincidentatrialfibrillationresultsfromaretrospectivecohortstudyusingalargeuscommercialinsurancedatabase